PRODUCT MONOGRAPH - GSK
Page 5of 23 As with all injectable vaccines, appropriate medical treatment and supervision should be readily available in case of a rare anaphylactic event following the administration of the
Download PRODUCT MONOGRAPH - GSK
Information
Domain:
Source:
Link to this page:
Documents from same domain
PRODUCT MONOGRAPH INCLUDING PATIENT …
ca.gsk.comPage 1 of 40 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrNUCALA Mepolizumab for Injection 100 mg/mL lyophilized powder for subcutaneous injection
PRODUCT MONOGRAPH INCLUDING PATIENT …
ca.gsk.comPage 1 of 49 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrTRELEGY ELLIPTA fluticasone furoate/umeclidinium (as bromide)/vilanterol (as trifenatate), dry powder for oral
FLULAVAL TETRA (2017-2018) - GSK.ca
ca.gsk.comFLULAVAL® TETRA (2017-2018) GlaxoSmithKline Approved: 21-Apr-2017 Page 1 of 25 PRODUCT MONOGRAPH FLULAVAL® TETRA (2017-2018) Quadrivalent Influenza Vaccine (Split Virion, Inactivated) Suspension for Injection
PRODUCT MONOGRAPH INCLUDING PATIENT …
ca.gsk.comPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ENGERIX-B Hepatitis B vaccine (recombinant) 0.5 mL and 1.0 mL suspensions of 20 mcg/mL hepatitis B surface antigen for injection Active immunizing agent against infection caused by allknown subtypes of hepatitis B virus ATC Code: J07BC01 GlaxoSmithKline Inc. 7333 Mississauga …
PRODUCT MONOGRAPH INCLUDING PATIENT …
ca.gsk.comPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION SHINGRIX Herpes Zoster vaccine (non-live recombinant, AS01B adjuvanted) Suspension for injection, 50 mcg Varicella Zoster Virus (VZV) glycoprotein E (gE), Intramuscular Injection Active Immunizing Agent GlaxoSmithKline Inc. 7333Mississauga Road Mississauga, Ontario L5N 6L4
Trelegy Ellipta - GSK.ca | GSK Canada
ca.gsk.comTrademarks are owned by or licensed to the GSK group of companies 1355/509/Trelegy Ellipta May 11, 2021 Product Monograph Master Template Template Date: September 2020
Sotrovimab Product Monograph
ca.gsk.comSotrovimabis indicated forthe treatment of mild to moderate coronavirus disease 2019 (COVID-19), confirmed by direct SARS-CoV-2 viral testing, in adults and adolescents (12 years of age and older weighing at least 40kg) who are at high risk for progressing to hospitalization and/or death.
Bexsero Product Monograph - GSK
ca.gsk.comvaccines, INFANRIX HEXA and PREVNAR, except for one group of subjects in study V72P12 who received BEXSERO alone at 2, 4 and 6 months of age and the routine vaccines at 3, 5 and 7 months of age. In study V72P13E1, which was an extension of V72P13, subjects who previously
Related documents
When to Order Contrast-Enhanced CT
www.aafp.orgContrast-Enhanced CT 314 . American Family Physician . www.aafp.org/afp. Volume 88, Number 5 September 1, 2013. HISTORY OF REACTIONS TO CONTRAST AGENTS
Dextrose Injection, USP - accessdata.fda.gov
www.accessdata.fda.govThe flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of